Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.
Simões EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, Llapur C, Baker J, Pérez Marc G, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Padilla MD, Richmond PC, Sarwar UN, Baber J, Koury K, Lino MM, Kalinina EV, Li W, Cooper D, Anderson AS, Swanson KA, Gurtman A, Munjal I; MATISSE (Maternal Immunization Study for Safety and Efficacy) Clinical Trial Group. Simões EAF, et al. Among authors: swanson ka. Obstet Gynecol. 2025 Jan 2. doi: 10.1097/AOG.0000000000005816. Online ahead of print. Obstet Gynecol. 2025. PMID: 39746212
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.
Madhi SA, Kampmann B, Simões EAF, Zachariah P, Pahud BA, Radley D, Sarwar UN, Shittu E, Llapur C, Pérez Marc G, Maldonado Y, Kachikis A, Zar HJ, Swanson KA, Lino MM, Anderson AS, Gurtman A, Munjal I. Madhi SA, et al. Among authors: swanson ka. Obstet Gynecol. 2025 Jan 2. doi: 10.1097/AOG.0000000000005817. Online ahead of print. Obstet Gynecol. 2025. PMID: 39746206
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine.
Modjarrad K, Che Y, Chen W, Wu H, Cadima CI, Muik A, Maddur MS, Tompkins KR, Martinez LT, Cai H, Ramos M, Mensah S, Cumbia B, Falcao L, McKeen AP, Chang JS, Fennell KF, Huynh KW, McLellan TJ, Sahasrabudhe PV, Chen W, Cerswell M, Garcia MA, Li S, Sharma R, Li W, Dizon KP, Duarte S, Gillett F, Smith R, Illenberger DM, Efferen KS, Vogel AB, Anderson AS, Şahin U, Swanson KA. Modjarrad K, et al. Among authors: swanson ka. NPJ Vaccines. 2024 Nov 20;9(1):229. doi: 10.1038/s41541-024-01013-9. NPJ Vaccines. 2024. PMID: 39567521 Free PMC article.
Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions.
Davis M, Towner W, DeHaan E, Jiang Q, Li W, Rahman F, Patton M, Wyper H, Lino MM, Sarwar UN, Majid-Mahomed Z, Mehta S, Howitt W, Cannon K, Kalinina E, Cooper D, Swanson KA, Anderson AS, Gurtman A, Munjal I. Davis M, et al. Among authors: swanson ka. Clin Infect Dis. 2024 Nov 11:ciae550. doi: 10.1093/cid/ciae550. Online ahead of print. Clin Infect Dis. 2024. PMID: 39523547
Characteristics in pediatric metabolic and bariatric surgery.
Swanson KA, Steinberger AE, Nickel KB, Keller M, Sprague JE, Nicol GE, Christopher Eagon J, Dimou FM, Eckhouse SR, Shakhsheer BA. Swanson KA, et al. Obes Res Clin Pract. 2024 Sep-Oct;18(5):396-399. doi: 10.1016/j.orcp.2024.10.002. Epub 2024 Oct 31. Obes Res Clin Pract. 2024. PMID: 39482117
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
Walsh EE, Pérez Marc G, Falsey AR, Jiang Q, Eiras D, Patton M, Polack FP, Llapur C, Doreski PA, Zareba AM, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gruber WC, Schmoele-Thoma B, Gurtman A. Walsh EE, et al. Among authors: swanson ka. N Engl J Med. 2024 Oct 17;391(15):1459-1460. doi: 10.1056/NEJMc2311560. N Engl J Med. 2024. PMID: 39413383 No abstract available.
Structure of anellovirus-like particles reveal a mechanism for immune evasion.
Liou SH, Boggavarapu R, Cohen NR, Zhang Y, Sharma I, Zeheb L, Mukund Acharekar N, Rodgers HD, Islam S, Pitts J, Arze C, Swaminathan H, Yozwiak N, Ong T, Hajjar RJ, Chang Y, Swanson KA, Delagrave S. Liou SH, et al. Among authors: swanson ka. Nat Commun. 2024 Aug 22;15(1):7219. doi: 10.1038/s41467-024-51064-8. Nat Commun. 2024. PMID: 39174507 Free PMC article.
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial.
Gayed J, Bangad V, Xu X, Mensa F, Cutler M, Türeci Ö, Şahin U, Modjarrad K, Swanson KA, Anderson AS, Gurtman A, Kitchin N; C4591054 Study Group. Gayed J, et al. Among authors: swanson ka. Vaccines (Basel). 2024 Jul 2;12(7):734. doi: 10.3390/vaccines12070734. Vaccines (Basel). 2024. PMID: 39066372 Free PMC article.
Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds.
Sher LD, Boakye-Appiah JK, Hill S, Wasserman E, Xu X, Maldonado Y, Walter EB, Muñoz FM, Paulsen GC, Englund JA, Talaat KR, Barnett ED, Kamidani S, Senders S, Simões EAF, Belanger K, Parikh V, Ma H, Wang X, Lu C, Cooper D, Koury K, Anderson AS, Türeci Ö, Şahin U, Swanson KA, Gruber WC, Gurtman A, Kitchin N, Sabharwal C. Sher LD, et al. Among authors: swanson ka. J Pediatric Infect Dis Soc. 2024 Aug 24;13(8):421-429. doi: 10.1093/jpids/piae062. J Pediatric Infect Dis Soc. 2024. PMID: 38860591 Free PMC article. Clinical Trial.
107 results